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Differentiating Anti-Lamina Lucida and Anti-Sublamina Densa Anti-
BMZ Antibodies by Indirect Immunofluorescence on 1.0 M Sodium 
Chloride-Separated Skin 
W. RAY GAMMON, M.D., ROBERT A . BRIGGAMAN, M.D. ALFRED 0. INMAN ,III, M.S., 
LAURINDA L. QUEEN, M .D. AND CLAYTON E. WHEELER, M.D. 
Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, U.S.A. 
Sixty-one bullous disease sera containing lgG anti-
BMZ antibodies were examined by indirect immunoflu-
orescence on intact skin and skin separated through the 
lamina Iucida by incubation in 1.0 M NaCl. All sera 
produced an indistinguishable pattern of linear immu-
nofluorescence on intact skin at dilutions of 1:10 or 
higher. On separated skin, antibodies bound to e ither 
the epidermal (epidermal pattern), dermal (dermal pat-
tern), or epidermal and dermal (combined pattern) sides 
of the separation. The binding patterns were consistent 
on separated skin from several donors and titers of anti-
basement membrane zone antibodies on separated skin 
were comparable to those on intact skin. Sera from 3 
patients with herpes gestationis (HG), 36 patients with 
bullous pemphigoid (BP), and 1 patient with clinical and 
histologic features of epidermolysis bullosa acquisita 
(EBA) showed an epidermal pattern. Sera from 9 pa-
tients with BP showed a combined pattern and sera from 
6 patients with EBA and 6 patients with clinical and 
histologic features of BP showed a dermal pattern. In-
direct immunoelectron microscopy of selected sera 
s howed antibodies producing the epidermal and com-
bined patterns were anti-lamina Iucida antibodies and 
those producing the dermal pattern were anti-sublamina 
densa antibodies. These results show indirect immuno-
fluorescence on separated skin is a dependable method 
for differentiating bullous disease anti-lamina lucida 
and anti-sublamina densa antibodies and that differen-
t iating between the antibodies is essential for accurate 
diagnosis in some patients. The results also suggest BP 
anti-lamina Iucida antibodies may have more than one 
a ntigenic specificity . 
Circulating and t issue-deposited lgG antibodies to t he cuta-
neous basement membrane zone (BMZ) are characteristic of 
patients with bullous pemphigoid (BP), cicatri cia l pemphigo id 
(CP) , herpes gestationis (HG), and epidermolysis bullosa ac-
quisita (EBA) [1-8]. By immunoelectron microscopy, anti -
BMZ antibodies can be divided in to two groups based on t heir 
ult rastructural binding s ites . In BP, CP, and HG t he antibodies 
bind to the lamina Iucida (anti-lamina Iucida a nt ibodies) and 
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BMZ: basement membrane zone 
BP: bullous pemphigoid 
CP: cicat ricial pemphigoid 
EBA: epidermolysis bu llosa acqui sita 
FITC: flu orescein isothiocyanate 
HG: herpes gestationis 
NHS: normal human serum 
in EBA, t hey bind along t he lower edge or just below t he lam ina 
densa (a nt i-sublamina densa ant ibodies) [5-12]. Anti-lamina 
Iucida and anti-sublami na densa ant ibodies can not be reliably 
distinguished using standard direct and indirect immunofluo-
rescence procedures and substrates because of t heir identical 
sta ining patterns. 
Due to the limited avai labil ity of immunoelectron micros-
copy, t he ultrast ructural binding sites of ant i-BMZ antibodies 
are seldom defined in bullous diseases, and differential diag-
nosis is based primarily on the clinica l and hi stologic features 
of t he diseases. T hese features may be misleading, especia lly in 
patients with BP, CP, and EBA in which features considered 
characteristic of one disease may be present in another. Since 
BP and CP a re characterized by anti -lamina Iucida antibodies 
and EBA by anti-sublamina densa antibodies, precise localiza-
t ion of anti-BMZ antibody binding sites could be of value in 
differential diagnosis. Furthermore, routine or more frequent 
determinat ion of ant ibody binding sites could provide a better 
understanding of t he cl inical, pathologic, a nd immunoul tra-
structural correlations in a ll bullous diseases associated with 
ant i- BMZ ant ibodies. 
In search of an a lternative to immunoelectron microscopy 
for different iating between anti- lamina Iucida and anti-sublam-
ina densa antibodies, we have investigated indirect immunof1u-
orescence us ing NaCl-treated hu man skin as substrate. One 
molar NaCI has previously been shown to separate the BMZ 
through the lamina Iucida leaving BP ant igen on t he epidermal 
side and components of t he lamina densa, type IV collage n, on 
the dermal side [1 3]. Using t his substrate, we examined sera 
containing a nt i-BMZ antibodies from 61 patients t hought to 
have BP, HG , or EBA based on clinical, hi stologic, and routine 
immunoh istologic crite ria. The results showed that anti-lamina 
Iucida an t ibodies from patients with BP and HG bound to t he 
epidermal or both ep idermal a nd de rmal sides of separated skin 
whil e anti -sublamina densa antibodies from patients with EBA 
bou nd only to the derma l s ide. Of inte rest was t he fi nding that 
6 patients thought to have BP and 1 patien t thought to have 
EBA by routine clinical, histo logic, a nd direct immunoflu ores-
cence crite ri a had anti-sub la mina densa and anti- lamina Iucida 
ant ibodies, respectively. In addi t ion , 9 BP sera had ant i-lam ina 
Iucida ant ibodies which consistent ly bound to both ep idermal 
and dermal sides of separated sk in while 36 BP sera had a nt i-
lam ina Iucida a ntibodies which consistent ly bou nd on ly to t he 
epidermal side. 
MATERIALS AND METHODS 
I mm.u.noreagents 
Rabbit. anti -laminin serum (specific immunoglobu lin concentration 
= 0.25 mg/ml) was purchased from Bethesda Research Labs, Ga ithers-
burg, Maryland and used at a di lution of 1:100 in 0.15 M NaCl buffered 
with 0.01 M Na1HP0.1 and 0.1 M NaH1 PO.,, pH 7.2 (PBS). Fluorescein 
isothiocyanate (FITC)-conjugaLed fgG fraction of goat anti human fgG 
and ant.irabbit lgG were purchased from Cappel Laboratories, Coch-
ranville, Pennsylvania. Specific antibody and molar flu orescein t.o 
protein ratios of these reagents were 2. 1 and 2.6, respectively for 
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antihuman IgG a nd 3.0 a nd 2.8 fo r a ntirabbit IgG. T hese conjugates 
were used at a dilution of 1:10- 1:20 in PBS. Bullous pemphigoid anti -
lamina Iucida and EBA anti -sublamina densa reference sera were 
obtained from 2 patients diagnosed by direct lgG immunoelectron 
microscopy. Specificity of these anti-BMZ antibodies for the lamina 
Iucida and sublam ina densa zone was confirmed by indirect lgG im -
munoelectron microscopy at a dilu t ion of 1:10. Titers of lgG anti-BMZ 
antibodies by indirect immu nofluorescence on in tact human sk in were 
1:1280 for BP and 1:320 for EBA. Reference sera were used at a dilution 
of 1:10 in PBS. 
Bullous Disease and Control Sera 
Control normal human sera (NHS) and bullous disease sera were 
obtained from 8 normal volunteers a nd 61 bullous disease patients with 
circulat ing lgG anti-BMZ antibodies at a t iter of at least 1:10 by 
standard indirect immunofluorescence testing. Bullous disease patients 
were diagnosed as BP (51), HG (3), and EBA (7) by accepted clini cal, 
histo logic, and im munohistologic features. Six patients with EBA and 
3 with BP were a lso diagnosed by direct lgG immunoelectron micros-
copy. Most patients were diagnosed by one of the authors; however, 
seve ral sera were generous gifts from Drs. E. H. Beutner, L. A. Diaz, 
S. 1. Katz, and W . M. Sams, Jr. All sera were heat-inactivated at 56· c 
for 30 min a nd stored frozen at -7o· c. 
Shin 
Strips of adu lt human skin app roximately 2.0 em wide and 10.0 em 
long were obtained from 3 fresh cadavers or surgical patients wi thout 
skin disease and subcutaneous fat scraped away. Sk in was rinsed in 
PBS and a 1 cm1 piece was cut from each str ip, quick -frozen in liquid 
N2, and stored frozen at -7o· c. T hese pieces were used as intact skin. 
Sodium Chloride Separation of Shin 
The remainder of the s kin strips were treated with 1.0 M NaCl using 
a previously described method [14]. Briefly, each strip was immersed 
in 50.0 ml of cold (4.C) 1.0 M NaCI in a 50-ml capped polystyrene tube 
and slowly rotated for 72 h at 4 ·c. Sodium chloride was exchanged at 
24 a nd 48 h. At the end of 72 h, strips were blotted on fil te r paper, 
placed epidermis side up in Petri dishes, and t he epide rmis gently 
dislodged from the dermis by lateral traction app lied to the skin with 
a tongue blade. T he epiderm is was left in place and strips cut into LO-
cm2 pieces with a razor blade. Some pi eces were quickly frozen in liquid 
N2, mounted in Ames O.C.T. compound (Ames Co., E lkhart, Indiana), 
a nd stored frozen at -7o· c. Several pieces were immediately fixed in 
2.5 % gluteraldehyde in 0.2 M Soresen's NaPO, buffer, pH 7.4 
Electron Microscopy 
Glutaraldehyde-fixed p ieces of each of the 3 strips of NaCI-separated 
skin were embedded a nd processed for routine electron microscopy 
according to previously described methods [15]. 
I ndirecL I mmtmo(luorescence 
Indirect immunofluorescence was performed on intact and separated 
human sk in using estab lished methods [1 6] . Specimens of separated 
s kin from each of the 3 donors were examined to localize laminin and 
antigens reactive with t he BP and EBA reference sera. All 61 bullous 
disease se ra were exam ined by lgG indirect immunofluorescence on 
intact and separated skin from l donor at a dilution of 1:10. Thirty-
eight of the BP- labeled sera and all HG - and EBA-labeled se ra were 
examined on separated skin from 3 donors at a titer of 1:10. Twenty-
one of the BP- and EBA- Iabeled sera were titered by doubling dilut ions 
with PBS from 1:10 to 1:20,480 a nd examined on one specimen of 
separated skin . 
Indirect lmmu.noelecLron Microscopy 
Indirect immu noelectron microscopy was performed on selected BP-
and EBA-labeled sera at a t ite r of 1:10 using 10- 12 l'm-thick cryostat 
sections of frozen intact or sepa rated skin and a previously described 
perox idase-antiperoxidase method (6] . 
RESULTS 
Ultrastructure of NaCl-Separated Skin 
Glutara ldehyde-fixed specimens of separated skin from each 
of 3 donors were examined by electron microscopy to determine 
the site of separation and preservation of BMZ structures. T he 
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results were similar in all 3 specimens. In each, dermis and 
e~idermis were separated primarily through the lamina Iucida 
w1th recogmzable basal cell p lasma membrane on t he epidermal 
s1de and lam ma densa_ on_ the dern~al_ s1de. The_ lamina densa 
showed some foca l t hmnmg and mfrequent disruptions but 
only rarely were fragments of lamina densa ad herent to the 
epidermal side of the separation . T he basal cell plasma mem-
brane also showed degenerative changes and interruptions but 
was only rarely seen attached to the dermal side of the sepa-
ration. Portions of lamina Iucida could be seen adherent to 
both plasma membrane and lamina densa. 
Localization of BMZ Antigens in NaCl-Separated Skin 
Frozen specimens of separated skin from each of t he 3 donors 
were examined by indirect immu nofluorescence using antibod-
ies to laminin and reference sera to BP and EBA ant igens. The 
FIG 1. a, Epidermal pattern of immunol1uorescence on LO M NaCl-
separated sk in produced by most BP and all HG sera (X250). b, 
Combined epidermal and dermal pattern of immonotluorescence on 
separated skin produced by a few BP sera (X250). c, Dermal pattern of 
immunofluorescence on separated skin produced by HBA- and BP-
labeled anti-sublamina densa antibodies (X400). 
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results of all 3 specimens were identical. Anti laminin produced 
a sha rp uninterrupted linear band of fluorescence along the 
dermal edge of t he separation with no staining on the epidermal 
side. Antibody to EBA antigen also produced a sharp, uninter-
rupted linear band of fluorescence along the dermal edge of the 
separation which was slightly brighter and wider t han that seen 
with antilaminin but otherwise indistinguishable. Antibody to 
BP ant igen produced a sha rp generally continuous band of 
fluorescence a long the epidermal edge of the separat ion. Occa-
s iona lly, irregularities and small interruptions in BP staining 
were seen but in no case was fluorescence seen on t he dermis. 
Indirect IgG Immunofluorescence of Bullous Disease and NHS 
on Intact and Separated Shin 
Each of t he 61 bullous disease and 8 NHS was examined at 
a t iter of 1:10 by indirect immunofluorescence on intact and 
separated skin fro m 1 donor. All 61 bullous disease sera pro-
duced a linear pattern of flu orescence at t he BMZ on intact 
skin. On separated skin bullous disease sera produced a linear 
pattern of fluorescence either along the epidermal side (epider-
mal pattern), dermal side (dermal pattern) , or both epidermal 
and dermal s ides (combined pattern) of t he separation (Fig 1) . 
Of 51 BP-labeled sera, 36 (71 %) showed an epidermal pattern , 
9 (17%) showed a combined pattern, and 6 (12%) showed a 
dermal pattern . All 3 HG-labeled sera showed an epidermal 
patte rn. Of 7 EBA-labeled sera, 1 showed an epidermal pattern 
and 6 showed a dermal pattern. No ne of the NHS showed 
fluoresce nce on intact or separated skin. These results are 
TABLE I. Resu.lts of lgG 1:n.direct ,:mmun.ofluorescence of bul.lous 
disease and control sera on sodium chloride-separated skin 
Serum Total Epidermal Combined Dermal 
groupa,b no. pattern pattern pattern 
sera 
Bullous pemphigoid 5 1 36 (71% ) 9 (17%) 6 (12 %) 
Herpes gestationis 3 3 (14 %) 0 0 
Epidermolysis bullosa 7 1 (14 %) 0 6 (86%) 
acqu isita 
Normal human 8 0 0 0 
a Sera diluted 1:10 in PBS. 
b Diagnosis based on clinical, histologic, and routine direct. immu-
nofluorescence criteria. 
summarized in Table I. Of interest was t he remarkably low 
background fluorescence observed with separated skin com-
pared to intact skin. 
To determine the reproducibility of the staining patterns, 27 
sera producing t he epidermal pattern (23 labe led BP, 1 labeled 
EBA, and 3 labe led HG) 9 sera producing t he combined pattern, 
12 sera producing the dermal pattern (6 labeled BP, 6 labeled 
EBA), and 8 NHS were examined on separated skin from each 
of 3 donors . On all 3 specimens, t he patterns of flu orescence 
were consistent for each bullous disease sera and no fluores-
cence was observed with NHS. 
To determine t he sensit ivi ty of separated skin as a substrate 
for detecti ng a nti-BMZ antibodies and further analyze BP-
labeled sera producing t he combined pattern of fluorescence, 
21 BP- and EBA- Iabeled sera were t itered in doubling dilutions 
from 1:10 to 1:20,480 on in tact and separated skin. These results 
are shown in Table II. Of 5 BP-Iabeled sera producing t he 
ep idermal pattern, t iters on separated skin were equal to or 1 
dilution greate r than on intact skin. Of 4 BP-Iabeled sera 
producing the dermal pattern, t iters on separated skin were 
consistently 1- 2 dilut ions greater t han on intact skin. Of 4 
EBA-labeled sera producing the dermal pattern, t iters were 1-
2 dilutions greate r on separated skin. These results show sep-
arated skin is at least as sensit ive a substrate as intact human 
sk in for t itering anti-BMZ antibodies. In no case did diluting 
sera cause a change in pattern from epidermal to dermal or 
vice versa. 
Of 8 se ra producing the combined pattern, derma l and epi-
dermal staining ant ibody titers were t he same in 3, higher on 
ep idermis in 4, and higher on dermis in 1. In several cases, t he 
t iter of ant i-BMZ on either the epidermal or dermal sides of 
t he separation was equal to or greater than t iters in intact skin. 
Indirect IgG Immunoelectron. Microscopy 
To correlate immunofluorescent patterns on separated skin 
with ult rast ructura l loca lization of ant ibody binding sites, se-
lected sera were exam ined by indirect lgG immunoelectron 
microscopy on separated or intact skin. The resul ts are shown 
in Table TIL Two BP and 1 EBA-labeled sera producing an 
epidermal pattern on sepa rated skin showed IgG deposi ts on 
the epidermal side of the separation within the lamina Iucida. 
These sera produced no deposits on the dermis. Two BP sera 
TABLE II. !gG an.ti-BMZ antibody titers of bu.llau.s dL~ease sera on. intact and ~odium chloride-separated skin 
Titers 
Disease Patterns on Serum Separated skin groupn separated sk in In tact sk in Epidermal Dermal 
Bullous pemphigoid Epidermal on ly BEl 10,240 20,480 
LYN 5,128 10,240 
MIL 10,240 10,240 
WIL 10,240 20,480 
MAR 5,128 10,240 
Bullous pemphigoid Combined epi- FAL 20 40 40 
dermal-der- MECI 80 320 80 
mal CAN 40 320 80 
FOR 160 320 320 
WAL 640 320 40 
ROL 10 40 80 
BOL 20 20 20 
WAT 40 40 20 
Bullous pemphigoid Dermal only DKI 320 1280 
DEV 40 80 
CONL 160 320 
CON 40 80 
Epidermolysis bullosa Dermal MAN 320 1280 
acquisita 560 80 160 
815 80 160 
CHO 40 80 
a Diagnosis based on clinical, histologic, and direct immunofluorescence criteria. 
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TABL E Ill. Correlation. of ultrastructural binding sites and binding 


















Ultrastructural No. sera bi nding tested 
s ite 
2 L amina lucida 
2 Lamina Iucida 
4 Subbasal lamina 
1 Lamina Iucida 
5 Subbasal lamina 
"Diagnosis based on clinical, histologic, and rout ine immunofluores-
cence criteria. 
with a combined pattern also showed deposits on t he epidermal 
side of separated skin bu t in addi tion showed deposits on that 
portion of the lamina Iucida which had remained attached to 
the lamina densa (Fig 2). Four BP-labeled sera and 5 EBA sera 
producing a de rmal pattern showed an ident ical deposit ion of 
im muno reactant on and just beneath the lamina densa (Fig 3) . 
No deposits were seen in t he lamina Iucida; however, occasion-
ally depos its we re seen beneath the basal lamina, anchoring 
fibril complex. These res ul ts confirmed the ul t rastructura l 
bind ing sites of a nti-BMZ ant ibodies producing the epidermal, 
dermal, and combined staining patterns on separated skin and 
showed t hat the "EBA serum" with ant i-lamina Iucida ant ibod-
ies and t he BP-labeled sera with ant i-sublamina densa ant ibod-
ies were fro m patients who were incorrectly diagnosed. 
DISCUSSION 
Im munoelectron microscopy is the only method currently 
ava il able for precisely determining t he ult rastructural binding 
sites of ant i-BMZ antibodies. However, it is tec hnically diffi -
cul t, t ime-consuming and of limited ava ilabili ty to practicing 
and academic dermato logists. Because of these limi tations, we 
exam ined sk in sepa rated t hrough the lamina Iucida by 1 M 
NaCl as a substrate for differentiating betwee n anti- lamina 
Iucida and anti -sublamina densa ant ibodies by indi rect immu-
nol1uo rescence. The resul ts showed that HG and BP anti-
lamina Iucida ant ibodies could be reliably and rep roducibly 
F1r. 2. Im mu noelectron mic rograph 
showing the dermal s ide of 1.0 M NaC I-
sepa rated skin t reated wi th combined 
pattern BP serum . Note imm une depos-
its (D) on the sepa ration (S) side of the 
lam ina densa (L). Bar = 0.5 JLm . 
Vo l. 82, N o.2 
different iated from EBA anti-sublamina densa ant ibodies by 
binding patterns on separated skin. 
Since ant i-lamina Iucida antibodies we re not ava ilable fr orn 
a patient with classica l CP, we cannot be certa in they could be 
different iated by the method. However, it is likely that Cp 
antibod~es would. produce a pattern. lik.e ~hat ~een wit h BP a n d 
H G ant tbodtes smce all three are md1stmgUtshable by irnrnu -
noelectron microscopy [7- 12]. The value of t he method is of 
course, limited by the incidence of a nt i-BMZ ant ibodies. In 'cp 
the incidence is probably less than 20%; however, in EBA a nd 
HG it appea rs to be at least 50% and greater than 70% in Bp 
[3,4,6,17-21] . In patients wi thout serum antibodies, a dou ble 
immunofluorescence method has been described for di ffe ren -
tiat ing between in vivo depos ited anti-lamina Iucida and a n ti-
sublamina densa ant ibodies [22]. 
One mola r NaCI-separated skin appeared to be at least as 
sensit ive as intact skin for detecting ant i-BMZ ant ibodies. In 
some cases, end-point t iters were 1-2 dilu t ions greate r in sep-
arated skin . This apparent increase in sensitivity may have 
been due to improved exposure of ant igen by the sepa ration 
process and/ or the low background fluorescence. The low back. 
ground l1uorescence is presumably due to removal of t issue 
immunoglobulin during the NaCl incubation. The sensit ivity 
of separated skin also suggests there is li t tle, if any, loss of or 
alteration in BP or EBA ant igens during t he separation process. 
Since the materials and reagents are ava ilable to any immu-
nofluorescence laboratory, t he method can be used in t he 
routine evaluation of anti-BMZ ant ibody binding sites. Once 
skin is sepa rated, it can be stored at - 7o·c and in our experi-
ence is sui table as substrate for at least 3 months. Alt hough we 
used electron microscopy to document t he site of sepa ration 
this can be easily confirmed by immunofluorescence a lone usin~ 
reference bullous disease se ra or commercia lly ava ila ble anti~ 
bodies to Jaminin . The fact that laminin is a lamina lucida 
constituent and separates to t he dermal side of 1 M NaCJ-
t reated skin does raise the possibility t hat bullous disease anti-
lamina Iucida ant ibodies which produce a dermal pattern m icrht 
be encoun tered [13,23]. However, t his was not observed in ~ur 
se ries of 49 bullous disease sera containing ant i-lamina lucida 
ant ibodies. Ant ilaminin autoa ntibodies have not been reported 
in bullous disease but even if they were, they should be distin-
gu ishable by their binding to vascula r as well as cutaneous 
basement membranes [23). 
Discriminating between ant i-sublamina densa and ant i-lam-
ina Iucida antibodies may be more important than previously 
; 
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realized, par t icula rly in patients with BP, CP, and EBA. In 
these diseases overlapp ing clinica l, histo logic, and immuno-
histologic features occur. For example, pat ients with EBA have 
been described with features considered characteristic of BP 
[24-26]. These include a genera lized inflam mato ry bullous di s-
ease with flexura l involvement, spontaneous blisters, hea ling 
of some lesions without scarring o r milia, a nd inflammatory 
subepidermal blisters. Patients have been reported as BP wi t h 
mechanical fragility of skin , trauma-induced blisters, and cu-
taneous and mucous membrane lesions t hat hea l with scarring 
and milia [27- 29]. Both EBA and CP are diseases which 
typ ically heal with scarring and both may have mucous mem-
bran e lesions including lesions of ocular mucous membranes 
(17 ,30-32]. It is conceivable t hat failure to define the ult rastruc-
t ural localizatio n of anti-BMZ ant ibodies in t hese diseases may 
have led to misdiagnoses a nd to the proposals t hat CP and 
EBA may be the same disease and t hat BP and CP may evolve 
into EBA [31,32]. 
The results of t his study showed that misdiagnoses can be 
made if t he ul trastructura l localization of anti-BMZ a nt ibodies 
is not determined. Sera from 6 pat ien ts suspected of having BP 
a nd 1 suspected of having EBA on t he basis of clinical, histo-
logic, a nd rout ine immunofluorescence cri te ria were shown to 
con tain anti-sublamina densa and anti-lamina Iucida antibod-
ies, respective ly. The patients init ia lly thought to have BP will 
be discussed in more detail in a separa te communication but, 
in b rief, t hey presented eit her with clinical features indistin-
guis h able from classic BP or combined features of both BP and 
EBA. Because these patients have immunoelectron microscopic 
features indistinguishable from classic EBA, we currently re-
gard t hem as being a variant of t hat disease. In t he 1 patient 
with clinical and histo logic fea tures of EBA and a nti-lamina 
Iuc ida antibodies t he diagnosis is not clea r but the localization 
of antibodies to t he la mina Iucida suggests a diagnosis of CP. 
T he patient had a scarring, blistering eruption localized to 
t rauma-susceptible sites of skin and oral mucous membranes 
but without ocula r involvement. 
In t his study, 9 (20%) of 45 BP se ra produced a combined 
pattern of immunofluorescence on separated skin from several 
donors. These results suggest some BP sera have anti-BMZ 
specificities different from or in addition to t hose BP sera 
producing only epidermal deposits on separated skin . Two of 
FIG 3. lmmunoelectron micrographs 
showing the BMZ of 1.0 M NaCI-sepa-
rat.ed skin treated with anti-sublamina 
densa antibody. Immune deposits (D) 
are present on and just beneath the lam-
ina den sa (L ). The site of separation (S) 
is seen between the lamina densa and 
the basal cell plasma membrane (P). Bar 
= 0.5 IJm . 
t he "combined sta ining" se ra have been examined by Dr. John 
Stanley, and shown to immunop rec ipi tate a 220,000 dalton 
protein ident ica l to t hat immunoprecipi tated by other BP sera 
(personal communication) [33]. T his would suggest t hat all BP 
anti- lamina Iucida an tibodies share an ident ical specificity a nd 
t hat t hose producing t he combined pattern may have addit ional 
specific it ies. 
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